GMEDIUM SIGNALFINANCIAL10-K

Company G shows strong operational cash generation and balance sheet growth, though accompanied by a notable increase in current liabilities.

The company appears to be in a growth phase with expanding operations, as evidenced by increased assets, cash flow, and debt levels. However, the substantial rise in current liabilities warrants monitoring to ensure the company maintains adequate liquidity management as it scales.

Comparing 2026-02-26 vs 2025-03-03View on EDGAR →
FINANCIAL ANALYSIS

The financial picture reveals a company actively expanding its operations with total assets growing 17.2% to $5.8B and operating cash flow increasing 32.1% to $812.9M. While the company strengthened its cash position by $205.6M to reach $853.8M, current liabilities grew substantially to $1.6B, representing a 66.3% increase that suggests higher working capital needs or increased short-term obligations. The company continued returning capital to shareholders through both dividends ($57.1M) and share buybacks ($252.7M), while outstanding shares decreased from 175.7M to 169.9M shares.

FINANCIAL STATEMENT CHANGES
Current Liabilities
Balance Sheet
+66.3%
$963.7M$1.6B

Current liabilities surged 66.3% — significant near-term obligations; verify ability to meet short-term debt.

Operating Cash Flow
Cash Flow
+32.1%
$615.4M$812.9M

Operating cash flow surged 32.1% — exceptional cash generation, highest quality earnings signal.

Cash & Equivalents
Balance Sheet
+31.7%
$648.2M$853.8M

Cash position surged 31.7% — strong cash generation or capital raise providing significant financial cushion.

Current Assets
Balance Sheet
+27.7%
$2.1B$2.7B

Current assets grew 27.7% — improving short-term liquidity or inventory/receivables build.

Total Liabilities
Balance Sheet
+26.8%
$2.6B$3.3B

Liabilities increased 26.8% — monitor debt-to-equity ratio and interest coverage.

Total Debt
Balance Sheet
+26.3%
$1.2B$1.5B

Debt rose 26.3% — additional borrowing for investment or operations; monitor coverage ratios.

Dividends Paid
Cash Flow
+22.3%
$46.7M$57.1M

Dividend payments increased 22.3% — management confidence in sustained cash generation.

Total Assets
Balance Sheet
+17.2%
$5.0B$5.8B

Asset base grew 17.2% — expansion through organic growth, acquisitions, or capital deployment.

Share Buybacks
Cash Flow
+12%
$225.5M$252.7M

Share repurchases increased 12% — management returning capital, signals confidence in intrinsic value.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-03-03
ADDED
As of February 24, 2026, there were 169,863,795 common shares of the registrant outstanding.
Management s Discussion and Analysis of Financial Condition and Results of Operations 50 7A.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 70 9A.
In particular, you should consider the numerous risks outlined under the heading Summary of Risk Factors and Item 1A Risk Factors in this Annual Report on Form 10-K.
You are advised, however, to consult any further disclosures we make on related subjects in our Forms 10-Q and Form 8-K reports to the Securities and Exchange Commission (the "SEC").
+7 more — sign up free →
REMOVED
As of February 20, 2025, there were 175,669,364 common shares of the registrant outstanding.
Management s Discussion and Analysis of Financial Condition and Results of Operations 45 7A.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 64 9A.
In particular, you should consider the numerous risks outlined under the heading Summary of Risk Factors and Item 1A Risk Factors in this Annual Report.
You are advised, however, to consult any further disclosures we make on related subjects in our Forms 10-Q and Form 8-K reports to the SEC.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →